CD4 and COVID-19: Looking at the activation as measured by HLA-DR and CD38 expression, we observed an increase of HLA-DR+CD38+ cells in the TM and EM subset of CD8+ T cells and in the CM and TM subset of CD4+ T cells in both COVID-19 and malaria patients compared to healthy controls.